The drug candidate is administered through oral route and formulated as film coated tablet and capsule. It is a small molecule which acts by targeting T-type calcium channel Cav3.1, Cav3.2, Cav3.3.
US health regulator reports recall of pharmaceutical products from Aurobindo Pharma, Glenmark, and Zydus due to manufacturing issues, including impurities and labeling errors. These actions underscore ...